These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19780258)

  • 61. Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 microg every 2 weeks) in anemic patients with cancer receiving chemotherapy.
    Waltzman R; Croot C; Justice GR; Fesen MR; Charu V; Williams D
    Oncologist; 2005 Sep; 10(8):642-50. PubMed ID: 16177289
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial.
    Wilkinson PM; Antonopoulos M; Lahousen M; Lind M; Kosmidis P;
    Br J Cancer; 2006 Apr; 94(7):947-54. PubMed ID: 16570051
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study.
    Rades D; Tribius S; Yekebas EF; Bahrehmand R; Wildfang I; Kilic E; Muellerleile U; Gross E; Schild SE; Alberti W
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):459-65. PubMed ID: 16584851
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B; van de Werf PR; Melissant CF; Brok RG
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life.
    Abrams DI; Steinhart C; Frascino R
    Int J STD AIDS; 2000 Oct; 11(10):659-65. PubMed ID: 11057937
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.
    Wright JR; Ung YC; Julian JA; Pritchard KI; Whelan TJ; Smith C; Szechtman B; Roa W; Mulroy L; Rudinskas L; Gagnon B; Okawara GS; Levine MN
    J Clin Oncol; 2007 Mar; 25(9):1027-32. PubMed ID: 17312332
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Epoetin alfa for protection of metabolic and exercise capacity in cancer patients.
    Daneryd P
    Semin Oncol; 2002 Jun; 29(3 Suppl 8):69-74. PubMed ID: 12082657
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W; Locatelli F; Ryckelynck JP; Balla J; Csiky B; Harris K; Ehrhard P; Beyer U;
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A prospective cohort study on the impact of darbepoetin alfa on quality of life in daily practice following anemia treatment guideline revisions.
    Steinmetz T; Kindler M; Lange O; Vehling-Kaiser U; Kuhn A; Hellebrand E
    Curr Med Res Opin; 2014 Sep; 30(9):1813-20. PubMed ID: 24849527
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Correction of anemia with epoetin alfa in chronic kidney disease.
    Singh AK; Szczech L; Tang KL; Barnhart H; Sapp S; Wolfson M; Reddan D;
    N Engl J Med; 2006 Nov; 355(20):2085-98. PubMed ID: 17108343
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
    Aapro M; Leonard RC; Barnadas A; Marangolo M; Untch M; Malamos N; Mayordomo J; Reichert D; Pedrini JL; Ukarma L; Scherhag A; Burger HU
    J Clin Oncol; 2008 Feb; 26(4):592-8. PubMed ID: 18235117
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancer.
    Welch RS; James RD; Wilkinson PM; Belli F; Cowan RA
    Cancer J Sci Am; 1995; 1(4):261-6. PubMed ID: 9166486
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Use of erythropoietin-stimulating agents in breast cancer patients: a risk review.
    Crouch Z; DeSantis ER
    Am J Health Syst Pharm; 2009 Jul; 66(13):1180-5. PubMed ID: 19535656
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients.
    Puglisi F; Deroma L; Russo S; Cartenì G; Sporchia A; Ucci G; De Signoribus G; Del Prete S; Vecchione A; Pinotti G; Beccaglia P
    Crit Rev Oncol Hematol; 2009 Feb; 69(2):175-82. PubMed ID: 18774730
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer scheduled to receive first-line chemotherapy.
    Crawford J; Robert F; Perry MC; Belani C; Williams D;
    J Thorac Oncol; 2007 Mar; 2(3):210-20. PubMed ID: 17410044
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.
    Leyland-Jones B; Semiglazov V; Pawlicki M; Pienkowski T; Tjulandin S; Manikhas G; Makhson A; Roth A; Dodwell D; Baselga J; Biakhov M; Valuckas K; Voznyi E; Liu X; Vercammen E
    J Clin Oncol; 2005 Sep; 23(25):5960-72. PubMed ID: 16087945
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial.
    Moebus V; Jackisch C; Schneeweiss A; Huober J; Lueck HJ; du Bois A; Thomssen C; Kurbacher C; Kuhn W; Nitz U; Runnebaum IB; Hinke A; Kreienberg R; Untch M;
    J Natl Cancer Inst; 2013 Jul; 105(14):1018-26. PubMed ID: 23860204
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa.
    Agnihotri P; Telfer M; Butt Z; Jella A; Cella D; Kozma CM; Ahuja M; Riaz S; Akamah J
    J Am Geriatr Soc; 2007 Oct; 55(10):1557-65. PubMed ID: 17697104
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prospective, randomized, controlled, and open study in primarily inoperable, stage III non-small cell lung cancer (NSCLC) patients given sequential radiochemotherapy with or without epoetin alfa.
    Debus J; Drings P; Baurecht W; Angermund R
    Radiother Oncol; 2014 Jul; 112(1):23-9. PubMed ID: 25129551
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The relationship between anemia and quality of life in cancer patients.
    Sabbatini P
    Oncologist; 2000; 5 Suppl 2():19-23. PubMed ID: 10896325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.